Abstract 15859: Fibroblast Growth Factor 23 and Myocardial Infarction in the Boston Puerto Rican Health Study

Chinedu Ochin; Joseph A Salami; Emir Veledar; Garelnabi; Katherine L. Tucker

doi:10.1161/circ.142.suppl_3.15859

Back

Abstract 15859: Fibroblast Growth Factor 23 and Myocardial Infarction in the Boston Puerto Rican Health Study

Journal article

Peer reviewed

Abstract 15859: Fibroblast Growth Factor 23 and Myocardial Infarction in the Boston Puerto Rican Health Study

Chinedu Ochin, Joseph A Salami, Emir Veledar, Garelnabi and Katherine L. Tucker

Circulation, Vol.142

2020

DOI: https://doi.org/10.1161/circ.142.suppl_3.15859

Abstract

Background: FGF-23 is an endocrine regulator of phosphate metabolism as well as also a potent biomarker that mediates cardiovascular remodeling, with markedly elevated plasma concentration associat...

Files and links (2)

url

https://lens.org/095-402-560-533-576View

url

https://www.ahajournals.org/doi/abs/10.1161/circ.142.suppl_3.15859?af=RView

Metrics

1 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Abstract 15859: Fibroblast Growth Factor 23 and Myocardial Infarction in the Boston Puerto Rican Health Study
Creators: Chinedu Ochin - University of Massachusetts Lowell
Joseph A Salami - Baptist Hospital of Miami
Emir Veledar - Baptist Hospital of Miami
Garelnabi
Katherine L. Tucker - University of Massachusetts Lowell
Publication Details: Circulation, Vol.142
Publisher: Ovid Technologies (Wolters Kluwer Health); United States
Academic Unit: Miller School of Medicine; UMMG Department of Neurology
Resource Type: Journal article
Record Identifier: 991031996605002976